Pascal J. Druzgala
Gründer bei Optivia Biotechnology, Inc.
Profil
Pascal J.
Druzgala is the founder.
He founded ARYx Therapeutics, Inc. in 1997 and held the title of Chief Scientific Officer & Senior Vice President.
He also founded Advanced Therapies, Inc. in 1994.
Dr. Druzgala is also the founder of Renexxion Ireland Ltd.
In addition to his founding positions, Dr. Druzgala has worked as a Director at Optivia Biotechnology, Inc. since 2007 and as the Senior Vice President-Research & Development at Armetheon, Inc. since 2013.
He previously worked as a Senior Scientist at Xenon Vision, Inc. Dr. Druzgala obtained a doctorate degree from the University of Florida in 1985 and another doctorate degree from Université de Montpellier in 1978.
Aktive Positionen von Pascal J. Druzgala
| Unternehmen | Position | Beginn |
|---|---|---|
Optivia Biotechnology, Inc.
 Optivia Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Optivia Biotechnology, Inc. provides contract research organization offering drug transporter research services and solutions to biotechnology, pharmaceutical and academic organizations. It offers regulatory DDI studies, transporter screening, tranporter profiling, and custom development services. The firm's products include TransFlex Single Transporter Assay Plates,TransFlex Multi-Transporter Model Plates, and Certified Efflux Transporter Vesicles. The company was founded by Yong Huang, Pascal Druzgala and Peter G. Milner in 2007 and is headquartered in Santa Clara, CA. | Gründer | 01.01.2007 |
Armetheon, Inc.
 Armetheon, Inc. Pharmaceuticals: MajorHealth Technology Armetheon, Inc. engages in medical development. It specializes in thrombosis and cardiac arrhythmias. The company was founded by Pascal J. Druzgala, Muralitharan Ken Kengatharan and Peter G. Milner in 2011 and is headquartered in Milpitas, CA. | Gründer | 01.01.2011 |
Renexxion LLC
 Renexxion LLC Pharmaceuticals: MajorHealth Technology Renexxion LLC is a gastrointestinal biopharmaceutical company. It develops naronapride. The company was founded by Peter G. Milner, Muralitharan Kengatharan , and Pascal J. Druzgala in 2014 and is headquartered in Menlo Park, CA. | Gründer | 01.01.2014 |
Ehemalige bekannte Positionen von Pascal J. Druzgala
| Unternehmen | Position | Ende |
|---|---|---|
Xenon Vision, Inc.
 Xenon Vision, Inc. Miscellaneous Commercial ServicesCommercial Services Part of W World Corp., Xenon Vision, Inc. is a vision research concern. The company is based in Alachua, FL. Xenon Vision was acquired by Pharmatec, Inc. on November 03, 1992. | Technik-/Wissenschafts-/F&E-Leiter | - |
| Advanced Therapies, Inc. | Gründer | - |
| ARYX THERAPEUTICS, INC. | Gründer | - |
Ausbildung von Pascal J. Druzgala
| University of Florida | Doctorate Degree |
| Université de Montpellier | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ARYX THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Optivia Biotechnology, Inc.
Optivia Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Optivia Biotechnology, Inc. provides contract research organization offering drug transporter research services and solutions to biotechnology, pharmaceutical and academic organizations. It offers regulatory DDI studies, transporter screening, tranporter profiling, and custom development services. The firm's products include TransFlex Single Transporter Assay Plates,TransFlex Multi-Transporter Model Plates, and Certified Efflux Transporter Vesicles. The company was founded by Yong Huang, Pascal Druzgala and Peter G. Milner in 2007 and is headquartered in Santa Clara, CA. | Health Technology |
Xenon Vision, Inc.
Xenon Vision, Inc. Miscellaneous Commercial ServicesCommercial Services Part of W World Corp., Xenon Vision, Inc. is a vision research concern. The company is based in Alachua, FL. Xenon Vision was acquired by Pharmatec, Inc. on November 03, 1992. | Commercial Services |
| Advanced Therapies, Inc. | |
Armetheon, Inc.
Armetheon, Inc. Pharmaceuticals: MajorHealth Technology Armetheon, Inc. engages in medical development. It specializes in thrombosis and cardiac arrhythmias. The company was founded by Pascal J. Druzgala, Muralitharan Ken Kengatharan and Peter G. Milner in 2011 and is headquartered in Milpitas, CA. | Health Technology |
Renexxion LLC
Renexxion LLC Pharmaceuticals: MajorHealth Technology Renexxion LLC is a gastrointestinal biopharmaceutical company. It develops naronapride. The company was founded by Peter G. Milner, Muralitharan Kengatharan , and Pascal J. Druzgala in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
